JIPMER enrolls India's first infant in NeoSep1 International Clinical Trial

Uniindia: Chennai, July 1 (UNI) The Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in Puducherry has achieved a significant milestone by becoming the first centre in India to enroll a newborn in the NeoSep1 international clinical trial to advance Neonatal Sepsis treatment.